GMED vs ITGR

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 09, 2026

GMED

40.4
AI Score
VS
ITGR Wins

ITGR

59.1
AI Score

Investment Advisor Scores

GMED

40score
Recommendation
HOLD

ITGR

59score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric GMED ITGR Winner
Revenue 1.55B 903.69M GMED
Net Income 275.87M 40.11M GMED
Net Margin 17.8% 4.4% GMED
Operating Income 332.82M 66.40M GMED
ROE 5.8% 2.3% GMED
ROA 5.0% 1.2% GMED
Total Assets 5.49B 3.42B GMED
Cash 507.75M 21.38M GMED
Current Ratio 4.62 3.73 GMED
Free Cash Flow 339.32M 37.78M GMED

Relative Price Performance (Last 90 Days)

GMED 1M: -13.4% · 3M: -7.9% ITGR 1M: +0.7% · 3M: +36.8%

Current Technical Phase

GMED

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 32

RSI (14): 31.6 · Price: $74.19

ITGR

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (13.5% over 20 days), RSI 76

RSI (14): 75.9 · Price: $126.00

Fundamentals Snapshot

Metric GMED ITGR
Market Cap
Forward P/E 13.7 18.3
Trailing P/E 19.1 34.4
Revenue (TTM)
Revenue Growth 0.1% 0.0%
Gross Margin 0.7% 0.3%
Operating Margin 0.2% 0.1%
EPS 3.86 3.66
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, ITGR is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.